G

G1 Therapeutics, Inc.

150 employees

G1 Therapeutics is a clinical-stage company developing small-molecule therapies to address significant unmet needs in oncology.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Developer Platform
Therapeutics
Medical
Cancer / Oncology
Drug Discovery and Development

Date founded

2008

Funding rounds raised

Total raised

$100M

from 12 investors over 12 rounds

G

G1 Therapeutics, Inc. raised $100M on June 1, 2020

Investors: Hercules Capital, Inc.

G

G1 Therapeutics, Inc. raised $47M on May 11, 2016

Investors: Lumira Ventures, Mountain Group Partners, RA Capital Management, L.P., Eshelman Ventures, LLC, Tavistock Group and Cowen Inc.

G

G1 Therapeutics, Inc. raised $33M on February 5, 2015

Investors: Eshelman Ventures, LLC, Mountain Group Partners, Lumira Ventures and RA Capital Management, L.P.

G

G1 Therapeutics, Inc. raised $13M on October 16, 2013

Investors: Mountain Group Partners

FAQ